Research Article
Efficacy and Predictive Factors of Oral Spironolactone Treatment in Chronic Central Serous Chorioretinopathy
Table 1
Visual acuity and imaging data during the follow-up of patients with chronic CSC treated with spironolactone.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CSC, central serous chorioretinopathy; SRF, subretinal fluid; BCVA, best-corrected visual acuity; CMT, central macular thickness; SFCT, subfoveal choroidal thickness; CCD, choriocapillaris density. † compared to baseline using the Wilcoxon paired signed-rank test. during the whole follow-up period according to repeated measure analysis of variance. |